Stembrook Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Hold
401
0.42% 25
2026
Q1
$369K Hold
401
0.36% 27
2025
Q4
$431K Buy
+401
New +$383K 0.41% 21

Other funds holding LLY

Stembrook Asset Management's LLY Position: Q2 2026 in Review

Stembrook Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 401 shares worth $481K. The position accounts for 0.42% of the portfolio, ranked #25.

Stembrook Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stembrook Asset Management held 401 shares of Eli Lilly worth $481K as of Q2 2026.
  • Stembrook Asset Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.42% of Stembrook Asset Management's portfolio in Q2 2026, its #25 holding.
  • Stembrook Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stembrook Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.